157 related articles for article (PubMed ID: 15567430)
1. Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs).
Gareri P; Condorelli D; Belluardo N; Russo E; Loiacono A; Barresi V; Trovato-Salinaro A; Mirone MB; Ferreri Ibbadu G; De Sarro G
Neuropharmacology; 2004 Dec; 47(8):1205-16. PubMed ID: 15567430
[TBL] [Abstract][Full Text] [Related]
2. Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice).
Gareri P; Condorelli D; Belluardo N; Citraro R; Barresi V; Trovato-Salinaro A; Mudò G; Ibbadu GF; Russo E; De Sarro G
Neuropharmacology; 2005 Sep; 49(4):551-63. PubMed ID: 15936783
[TBL] [Abstract][Full Text] [Related]
3. EEG wavelet analyses of the striatum-substantia nigra pars reticulata-superior colliculus circuitry: audiogenic seizures and anticonvulsant drug administration in Wistar audiogenic rats (War strain).
Rossetti F; Rodrigues MC; de Oliveira JA; Garcia-Cairasco N
Epilepsy Res; 2006 Dec; 72(2-3):192-208. PubMed ID: 17150334
[TBL] [Abstract][Full Text] [Related]
4. Seizures and proto-oncogene expression of fos in the brain of adult genetically epilepsy-prone rats.
Clough RW; Eells JB; Browning RA; Jobe PC
Exp Neurol; 1997 Aug; 146(2):341-53. PubMed ID: 9270043
[TBL] [Abstract][Full Text] [Related]
5. Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice.
Gareri P; Condorelli D; Belluardo N; Gratteri S; Ferreri G; Donato Di Paola E; De Sarro A; De Sarro G
Eur J Pharmacol; 2004 Jan; 484(1):49-56. PubMed ID: 14729381
[TBL] [Abstract][Full Text] [Related]
6. Unilateral microinjection of carbenoxolone into the pontis caudalis nucleus inhibits the pentylenetetrazole-induced epileptiform activity in rats.
Franco-Pérez J; Ballesteros-Zebadúa P; Manjarrez-Marmolejo J
Neurosci Lett; 2015 Aug; 602():38-43. PubMed ID: 26141611
[TBL] [Abstract][Full Text] [Related]
7. Vigabatrin for focal drug delivery in epilepsy: bilateral microinfusion into the subthalamic nucleus is more effective than intranigral or systemic administration in a rat seizure model.
Bröer S; Backofen-Wehrhahn B; Bankstahl M; Gey L; Gernert M; Löscher W
Neurobiol Dis; 2012 May; 46(2):362-76. PubMed ID: 22342648
[TBL] [Abstract][Full Text] [Related]
8. Effect of precollicular transection on audiogenic seizures in genetically epilepsy-prone rats.
Browning RA; Wang C; Nelson DK; Jobe PC
Exp Neurol; 1999 Feb; 155(2):295-301. PubMed ID: 10072305
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant drugs and the genetically epilepsy-prone rat.
Dailey JW; Jobe PC
Fed Proc; 1985 Jul; 44(10):2640-4. PubMed ID: 3924665
[TBL] [Abstract][Full Text] [Related]
10. Neuronal networks in the genetically epilepsy-prone rat.
Faingold CL
Adv Neurol; 1999; 79():311-21. PubMed ID: 10514823
[TBL] [Abstract][Full Text] [Related]
11. Antiepileptic effect of gap-junction blockers in a rat model of refractory focal cortical epilepsy.
Nilsen KE; Kelso AR; Cock HR
Epilepsia; 2006 Jul; 47(7):1169-75. PubMed ID: 16886980
[TBL] [Abstract][Full Text] [Related]
12. Evidence that carbamazepine and antiepilepsirine may produce a component of their anticonvulsant effects by activating serotonergic neurons in genetically epilepsy-prone rats.
Yan QS; Mishra PK; Burger RL; Bettendorf AF; Jobe PC; Dailey JW
J Pharmacol Exp Ther; 1992 May; 261(2):652-9. PubMed ID: 1374472
[TBL] [Abstract][Full Text] [Related]
13. Anticonvulsant effects of the 3-hydroxyanthranilic acid dioxygenase inhibitor NCR-631.
Luthman J
Amino Acids; 2000; 19(1):325-34. PubMed ID: 11026503
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): a microinjection study.
Yan QS; Dailey JW; Steenbergen JL; Jobe PC
Brain Res; 1998 Jan; 780(2):199-209. PubMed ID: 9507130
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical correlates of antiepileptic drugs in the genetically epilepsy-prone rat (GEPR).
Dailey JW; Yan QS; Adams-Curtis LE; Ryu JR; Ko KH; Mishra PK; Jobe PC
Life Sci; 1996; 58(4):259-66. PubMed ID: 8538363
[TBL] [Abstract][Full Text] [Related]
16. Effect of central microinjection of carbenoxolone in an experimental model of focal cerebral ischemia.
Khorasani MZ; Hosseinzadeh SA; Vakili A
Pak J Pharm Sci; 2009 Oct; 22(4):349-54. PubMed ID: 19783510
[TBL] [Abstract][Full Text] [Related]
17. The genetically epilepsy-prone rat: an overview of seizure-prone characteristics and responsiveness to anticonvulsant drugs.
Reigel CE; Dailey JW; Jobe PC
Life Sci; 1986 Sep; 39(9):763-74. PubMed ID: 3747727
[TBL] [Abstract][Full Text] [Related]
18. Antiepileptic effect of carbenoxolone on seizures induced by 4-aminopyridine: a study in the rat hippocampus and entorhinal cortex.
Medina-Ceja L; Cordero-Romero A; Morales-Villagrán A
Brain Res; 2008 Jan; 1187():74-81. PubMed ID: 18031716
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant effects of intracerebroventricularly administered norepinephrine are potentiated in the presence of monoamine oxidase inhibition in severe seizure genetically epilepsy-prone rats (GEPR-9s).
Mishra PK; Kahle EH; Bettendorf AF; Dailey JW; Jobe PC
Life Sci; 1993; 52(17):1435-41. PubMed ID: 8464344
[TBL] [Abstract][Full Text] [Related]
20. Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: prediction of clinical response.
Dailey JW; Cheong JH; Ko KH; Adams-Curtis LE; Jobe PC
Neurosci Lett; 1995 Aug; 195(2):77-80. PubMed ID: 7478272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
